UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (12), p.2489-2500

2015

Volltextzugriff (PDF)

Abstract B05: Discovery, validation and targeting of novel synthetic lethal interactions in academic drug discovery

Molecular cancer therapeutics, 2017-10, Vol.16 (10_Supplement), p.B05-B05

2017

Volltextzugriff (PDF)

Expression and Regulation of Chemokines in Murine and Human Type 1 Diabetes

Diabetes (New York, N.Y.), 2012-02, Vol.61 (2), p.436-446

2012

Volltextzugriff (PDF)

Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound

Journal of the American College of Surgeons, 2016-08, Vol.223 (2), p.399-407

2016

Volltextzugriff (PDF)

Positive margin rates following breast-conserving surgery for stage I–III breast cancer: palpable versus nonpalpable tumors

The Journal of surgical research, 2012-09, Vol.177 (1), p.109-115

2012

Volltextzugriff (PDF)

Dosimetry and pharmacokinetics of 177LuLu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2024-07, Vol.51 (8), p.2428

2024

Volltextzugriff (PDF)

Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

European journal of nuclear medicine and molecular imaging, 2024-07, Vol.51 (8), p.2428-2441

2024

Volltextzugriff (PDF)

Combined Inhibition of PI3Kβ and mTOR Inhibits Growth of PTEN-null Tumors

Molecular cancer therapeutics, 2018-11, Vol.17 (11), p.2309-2319

2018

Volltextzugriff (PDF)

Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models

NPJ breast cancer, 2023-08, Vol.9 (1), p.64-64, Article 64

2023

Volltextzugriff (PDF)

Test Performance Characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease

Annals of the American Thoracic Society, 2018-08, Vol.15 (8), p.926-934

2018

Volltextzugriff (PDF)

Abstract 3160: Sustained MAPK activation as a mechanism of resistance to osimertinib plus selumetinib in models of EGFR -mutant cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3160-3160

2017

Volltextzugriff (PDF)

Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models

NPJ breast cancer, 2023-09, Vol.9 (1), p.76-76, Article 76

2023

Volltextzugriff (PDF)

Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models

NPJ breast cancer, 2023-08, Vol.9 (1), p.69-69, Article 69

2023

Volltextzugriff (PDF)

Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer

Cell Metabolism, 2016-01, Vol.23 (1), p.77-93

2016

Volltextzugriff (PDF)

Did dog ownership influence perceptions of adult health and wellbeing during and following the Canterbury earthquakes? A qualitative study

Australasian journal of disaster and trauma studies, 2015-11, Vol.19 (2), p.67-75

Coombs, Samuel

2015

Volltextzugriff (PDF)

Abstract A109: AZD9291: an irreversible, potent and selective third generation tyrosine kinase inhibitor (TKI) targeting EGFR activating (EGFRm+) and resistance (T790M) mutations in advanced lung adenocarcinoma

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.A109-A109

2013

Volltextzugriff (PDF)

Positive Margins Rates Following Breast-Conserving Surgery for Stage I–III Breast Cancer: Palpable versus Non-Palpable Tumors

The Journal of surgical research, 2012-04, Vol.177 (1), p.109-115

2012

Volltextzugriff (PDF)

A paper chromatographic method for the measurement of pregnanediol in urine

The journal of clinical endocrinology and metabolism, 1958-03, Vol.18 (3), p.300-309

1958

Volltextzugriff (PDF)

Partenariats public-privé et coopération internationale

Annuaire suisse de politique de développement, 2005

2005

Volltextzugriff (PDF)

A SIMPLIFIED METHOD FOR THE ROUTINE MEASUREMENT OF URINARY ESTRIOL

The journal of clinical endocrinology and metabolism, 1958-11, Vol.18 (11), p.1274-1284

1958

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(21)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Humans
(6)
Oncology
(5)
Animals
(4)
Mice
(4)
Aged
(3)
Cell Line, Tumor
(3)
Endocrinology & Metabolism
(3)
Middle Aged
(3)
Author
(2)
Breast Cancer
(2)
Breast Neoplasms - Pathology
(2)
Breast Neoplasms - Surgery
(2)
Carcinoma, Ductal, Breast - Pathology
(2)
Carcinoma, Ductal, Breast - Surgery
(2)
Cell Biology
(2)
Female
(2)
Signal Transduction
(2)
Surgery
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models

Abstract B05: Discovery, validation and targeting of novel synthetic lethal interactions in academic drug discovery

Expression and Regulation of Chemokines in Murine and Human Type 1 Diabetes

Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound

Positive margin rates following breast-conserving surgery for stage I–III breast cancer: palpable versus nonpalpable tumors

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma

Dosimetry and pharmacokinetics of 177LuLu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours

Combined Inhibition of PI3Kβ and mTOR Inhibits Growth of PTEN-null Tumors

Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models

Test Performance Characteristics of the AIR, GAD-7, and HADS-Anxiety Screening Questionnaires for Anxiety in Chronic Obstructive Pulmonary Disease

Abstract 3160: Sustained MAPK activation as a mechanism of resistance to osimertinib plus selumetinib in models of EGFR -mutant cancer

Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models

Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models

Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer

Did dog ownership influence perceptions of adult health and wellbeing during and following the Canterbury earthquakes? A qualitative study

Abstract A109: AZD9291: an irreversible, potent and selective third generation tyrosine kinase inhibitor (TKI) targeting EGFR activating (EGFRm+) and resistance (T790M) mutations in advanced lung adenocarcinoma

Positive Margins Rates Following Breast-Conserving Surgery for Stage I–III Breast Cancer: Palpable versus Non-Palpable Tumors

A paper chromatographic method for the measurement of pregnanediol in urine

Partenariats public-privé et coopération internationale

A SIMPLIFIED METHOD FOR THE ROUTINE MEASUREMENT OF URINARY ESTRIOL

Suchergebnisse filtern